{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:07:24Z","timestamp":1740128844452,"version":"3.37.3"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,2]]},"DOI":"10.1093\/cid\/ciaa1756","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T20:16:43Z","timestamp":1605557803000},"page":"e3083-e3084","source":"Crossref","is-referenced-by-count":2,"title":["Identifying the Patients Most Likely to Die from Cryptococcal Meningitis: Time to Move from Recognition to Intervention"],"prefix":"10.1093","volume":"73","author":[{"given":"Neil R H","family":"Stone","sequence":"first","affiliation":[{"name":"Hospital for Tropical Diseases, University College London Hospitals, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7522-0281","authenticated-orcid":false,"given":"Ilan S","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"2021110300270127400_CIT0001","article-title":"Cryptococcal antigen in serum and cerebrospinal fluid for detecting cryptococcal meningitis in adults living with HIV: systematic review and meta-analysis of diagnostic test accuracy studies","author":"Temfack","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021110300270127400_CIT0002","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"N Engl J Med"},{"key":"2021110300270127400_CIT0003","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1186\/s13063-018-3026-4","article-title":"AMBIsome Therapy Induction OptimisatioN (AMBITION): high dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a phase 3 randomised controlled non-inferiority trial","volume":"19","author":"Lawrence","year":"2018","journal-title":"Trials"},{"key":"2021110300270127400_CIT0004","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/ciy515","article-title":"Short-course high-dose liposomal amphotericin B for human immunodeficiency virus-associated cryptococcal meningitis: a phase 2 randomized controlled trial","volume":"68","author":"Jarvis","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021110300270127400_CIT0005","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","article-title":"Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study","volume":"16","author":"Rhein","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2021110300270127400_CIT0006","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.amjmed.2019.04.026","article-title":"Presentation and mortality of cryptococcal infection varies by predisposing illness: a retrospective cohort study","volume":"132","author":"Hevey","year":"2019","journal-title":"Am J Med"},{"key":"2021110300270127400_CIT0007","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1749","article-title":"Cerebrospinal fluid lactate as a prognostic marker of disease severity and mortality in cryptococcal meningitis","author":"Abassi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021110300270127400_CIT0008","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021110300270127400_CIT0009","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAD.0b013e328333c005","article-title":"Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure","volume":"24","author":"Loyse","year":"2010","journal-title":"AIDS"},{"key":"2021110300270127400_CIT0010","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3390\/jcm9030781","article-title":"Tuberculosis in HIV-associated cryptococcal meningitis is associated with an increased risk of death","volume":"9","author":"Rutakingirwa","year":"2020","journal-title":"J Clin Med"},{"key":"2021110300270127400_CIT0011","first-page":"28","article-title":"Aspiring antifungals: review of current antifungal pipeline developments.","volume":"6","author":"Gintjee","year":"2020"},{"key":"2021110300270127400_CIT0012","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive dexamethasone in HIV-associated cryptococcal meningitis","volume":"374","author":"Beardsley","year":"2016","journal-title":"N Engl J Med"},{"key":"2021110300270127400_CIT0013","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5582\/ddt.2016.01054","article-title":"The use of mannitol in HIV-infected patients with symptomatic cryptococcal meningitis","volume":"10","author":"Hu","year":"2017","journal-title":"Drug Discov Ther"},{"key":"2021110300270127400_CIT0014","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/infdis\/jiy286","article-title":"Novel treatment of cryptococcal meningitis via neurapheresis therapy","volume":"218","author":"Smilnak","year":"2018","journal-title":"J Infect Dis"},{"key":"2021110300270127400_CIT0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.12688\/wellcomeopenres.15464.1","article-title":"Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana","volume":"4","author":"Tenforde","year":"2019","journal-title":"Wellcome Open Res"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1756\/39604574\/ciaa1756.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/9\/e3083\/41060118\/ciaa1756.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/9\/e3083\/41060118\/ciaa1756.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:28:05Z","timestamp":1635899285000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/9\/e3083\/5989324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":15,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,11,18]]},"published-print":{"date-parts":[[2021,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1756","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"type":"print","value":"1058-4838"},{"type":"electronic","value":"1537-6591"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2020,11,18]]}}}